SavedAdd your journal

Journals / Turkish Journal of Pediatrics / 2019 / Cilt: 61 - Sayı: 4

Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases

Ahu KARA
İlker DEVRİM
İlknur ÇAĞLAR
Nuri BAYRAM
Selcen KUNDAK
Hurşit APA
Emir Volkan ALTAN
Pages
538–543
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Consequently, ophthalmological evaluation should be performed bothat the time of diagnosis and before hospital discharge.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Stevens-Johnson syndrome and toxic epidermal necrolysis are severe cutaneousadverse reactions commonly caused by exposure to drugs and can end upwith significant morbidity and mortality.
📊
Key Findings & Data:The median period of stay inhospital was 13.5 days.
💡
Conclusion & Impact:Consequently, ophthalmological evaluation should be performed bothat the time of diagnosis and before hospital discharge.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Stevens-Johnson syndrome and toxic epidermal necrolysis are severe cutaneousadverse reactions commonly caused by exposure to drugs and can end upwith significant morbidity and mortality. We reported our experience withsix patients who were diagnosed with Stevens-Johnson Syndrome or ToxicEpidermal Necrolysis with a different clinical presentation. In patients, drugsand Mycoplasma pneumoniae infection were implicated as a trigger. IntravenousImmunoglobulin treatment was given to all patients, and intensive treatmentwas applied for skin and mucosal lesions. The median period of stay inhospital was 13.5 days. The most common long-term complication was ocularinvolvement. Among six patients, corneal epithelial defects occurred in onepatient. Consequently, ophthalmological evaluation should be performed bothat the time of diagnosis and before hospital discharge.

🔖

Cite This Article

KARA, A., DEVRİM, İ., ÇAĞLAR, İ., BAYRAM, N., KUNDAK, S., APA, H., ALTAN, E. V. (2019). Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases. Turkish Journal of Pediatrics, Cilt: 61 - Sayı: 4, 538–543. https://ajindex.com/articles/412023

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Martínez-Cabriales SA, Gómez-Flores M, OcampoCandiani J. Actualidades en farmacodermias severas: síndrome de Stevens-Johnson (SSJ) y necrólisis epidérmica tóxica (NET). Gac Med Mex 2015; 151: 777-787
  2. Ferrandiz-Pulido C, Garcia-Patos V. A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Arch Dis Child 2013; 98: 998- 1003
  3. Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 2011; 7: 803- 813
  4. Roujeau J, Bastuji-Garin S. Systematic review of treatments for Stevens- Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality. Ther Adv Drug Saf 2011; 2: 87-94
  5. Spies M, Sanford AP, Aili Low JF, Wolf SE, Herndon DN. Treatment of extensive toxic epidermal necrolysis in children. Pediatrics 2001; 108: 1162-1168
  6. French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int 2006; 55: 9-16
  7. Revuz J, Penso D, Roujeau JC, et al. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol 1987; 123: 1160-1165
  8. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-96
  9. Kunimi Y, Hirata Y, Aihara M, Yamane Y, Ikezawa Z. Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan. Allergol Int 2011; 60: 525-532
  10. Wetter DA, Camilleri MJ. Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. Mayo Clinic Proc 2010; 85: 131-138
  11. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005; 64: 1134-1138
  12. Çekiç Ş, Canıtez Y, Sapan N. Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience. Turk Pediatri Ars 2016; 51: 152-158
  13. Mawson AR, Eriator I, Karre S. Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role? Med Sci Monit 2015; 21: 133-143
  14. Dodiuk-Gad RP, Chung WH, Valeyrie-Allanore L, Shear NH. Stevens-Johnson syndrome and toxic epidermal necrolysis: An update. Am J Clin Dermatol 2015; 16: 475-493
  15. Barron SJ,